ARCHIVES

Advisors approve set-aside for alternative medicine “best case series.”

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990

Reauthorization Still Held up

September 30, 1988

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco

September 24, 1999

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001